Cross-clade detection of HIV-1-specific cytotoxic T lymphocytes does not reflect cross-clade antiviral activity

The Journal of Infectious Diseases
Michael S BennettOtto O Yang

Abstract

The genetic divergence of human immunodeficiency virus (HIV)-1 into distinct clades is a serious consideration for cytotoxic T lymphocyte (CTL)-based vaccine development. Demonstrations that CTLs can cross-recognize epitope sequences from different clades has been proposed as offering hope for a single vaccine. Cross-clade CTL data, however, have been generated by assessing recognition of exogenous peptides. The present study compares HIV-1-specific CTL cross-clade epitope recognition of exogenously loaded peptides with suppression of HIV-1-infected cells. Despite apparently broad cross-clade reactivity of CTLs against the former, CTL suppression of HIV-1 strains with corresponding epitope sequences is significantly impaired. The functional avidity of CTLs for nonautologous clade epitope sequences is diminished, suggesting that CTLs can fail to recognize levels of infected endogenously derived cell-surface epitopes despite recognizing supraphysiologic exogenously added epitopes. These data strongly support clade-specific antiviral activity of CTLs and call into question the validity of standard methods for assessing cross-clade CTL activity or CTL antiviral activity in general.

References

Nov 21, 1991·The New England Journal of Medicine·E D ShapiroJ D Clemens
May 29, 2001·Nature Immunology·B D Walker, B T Korber
Nov 21, 2001·British Medical Bulletin·B KorberV Detours
Oct 25, 2002·AIDS Research and Human Retroviruses·Sheila M KeatingLucy M Carruth
Jan 28, 2003·Trends in Immunology·Otto O Yang
May 14, 2003·The Journal of Experimental Medicine·Otto O YangBruce D Walker
Oct 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ayub AliOtto O Yang
Mar 24, 2004·Trends in Immunology·Otto O Yang
Aug 17, 2004·AIDS Research and Human Retroviruses·Alleluiah RutebemberwaFrances Gotch
Dec 8, 2004·The Journal of Experimental Medicine·Jean K LeeAndrew J McMichael
Dec 17, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Vanessa François-BongarconJudy Lieberman
Aug 3, 2005·AIDS Research and Human Retroviruses·André InwoleyUNKNOWN ANRS 1220 PRIMO-CI Study Group
Oct 27, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Lyle R McKinnonFrancis A Plummer

❮ Previous
Next ❯

Citations

Jun 7, 2008·Nature Medicine·David I WatkinsWayne C Koff
May 15, 2009·Journal of Virology·Bette T KorberBarton F Haynes
Feb 19, 2010·Journal of Virology·Mauricio A MartinsDavid I Watkins
Oct 31, 2008·Trends in Microbiology·Laura E Valentine, David I Watkins
Sep 25, 2012·Immunity·Philip J R Goulder, Bruce D Walker
Dec 3, 2013·Journal of Immunological Methods·Marloes A NaardingJill Gilmour
Jan 11, 2008·The Journal of Infectious Diseases·M Patricia D'Souza, Marcus Altfeld
Jan 30, 2015·AIDS·Marie Patricia DʼSouza, Otto O Yang
Jun 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·John T LoffredoAlessandro Sette
Mar 18, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Victor Y DuPaul A Goepfert
Dec 10, 2008·International Reviews of Immunology·Marc P Girard, Geetha P Bansal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.